Spyre Therapeutics Inc: Mizuho Raises Target Price to $120 From $84
SYRE•Related News
Nasdaq trade halt continues UCFIW.O reason not available at 09:00 AM
UCFIW•
SAP CFO Asam says AI exposes costly patchwork IT at banks and insurers
SAP•
SLB OneSubsea wins Eni EPC contract for Baleine Phase 3 offshore Côte d'Ivoire
SLB•
Gloo Holdings announces availability of press release on public offering closing
GLOO•
BUZZ-Niagen rises after U.S., EU rare disease designations for drug candidate
NAGE•